SCHEMBL7735676

SCHEMBL7735676

COc1c(C)cc(C)c(OC)c1C(=O)P(=O)(C(=O)c1c(C(F)(F)F)cccc1C(F)(F)F)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
EPHX2 P34913 1/20 0.34
MAOB P27338 1/20 0.34
SLC6A9 P48067 1/20 0.34
LMNA P02545 3/20 0.34
TAS2R14 Q9NYV8 2/20 0.34
GAA P10253 2/20 0.34
MAPT P10636 2/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187033 0.87 MAPT (0.40) CTSSMEN1KMT2AKDM4EALDH1A1
SCHEMBL7180917 0.85 TAS2R14 (0.39) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL7189020 0.85 KDM4E (0.40) MEN1KMT2AKDM4ECYP2C19MAPT
SCHEMBL7175290 0.83 ALDH1A1 (0.39) KDM4EALDH1A1LMNATAS2R14GAA
SCHEMBL7722886 0.83 SLC6A9 (0.40) CTSSMEN1KMT2AKDM4EALDH1A1
SCHEMBL7188372 0.83 MAOB (0.39) MEN1KMT2AKDM4EMAOBSLC6A9
SCHEMBL7187566 0.83 LMNA (0.39) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL7179453 0.83 TAS2R14 (0.37) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL7177059 0.83 SLC6A9 (0.45) MEN1KMT2AKDM4EMAOBSLC6A9
SCHEMBL7186785 0.83 LMNA (0.44) MEN1KMT2AKDM4EALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 CTSS 4218/4885MEN1 2263/4885KMT2A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.